Cramer Rosenthal Mcglynn LLC / BUWA
Cramer Rosenthal Mcglynn LLC’s Bio Rad Labs Inc Position
Does Cramer Rosenthal Mcglynn LLC own Bio Rad Labs Inc (BUWA)? Not currently — the last reported position was 64.3K shares worth $23M in Q3 2023; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$23M
Q3 2023
Shares
64.3K
% of Portfolio
+1.29%
Quarters Held
20
position exited
Position History BUWA
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q3 2023 | 64.3K | $23M | +1.29% |
| Q2 2023 | 67.6K | $26M | +1.28% |
| Q1 2023 | 81.1K | $39M | +1.75% |
| Q4 2022 | 79.0K | $33M | +1.46% |
| Q3 2022 | 59.0K | $25M | +1.18% |
| Q2 2022 | 45.3K | $22M | +1.03% |
| Q1 2022 | 28.5K | $16M | +0.63% |
| Q4 2021 | 29.4K | $22M | +0.72% |
| Q3 2021 | 29.9K | $22M | +0.76% |
| Q2 2021 | 30.6K | $20M | +0.63% |
| Q1 2021 | 32.6K | $19M | +0.62% |
| Q4 2020 | 50.9K | $30M | +0.93% |
| Q3 2020 | 74.4K | $38M | +1.55% |
| Q2 2020 | 84.0K | $38M | +1.53% |
| Q1 2020 | 147.3K | $52M | +2.43% |
| Q4 2019 | 154.1K | $57M | +1.62% |
| Q3 2019 | 167.8K | $56M | +1.58% |
| Q2 2019 | 174.0K | $54M | +1.49% |
| Q1 2019 | 179.4K | $55M | +1.31% |
| Q4 2018 | 200.7K | $47M | +1.18% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Cramer Rosenthal Mcglynn LLC’s full portfolio or all institutional holders of BUWA.